Literature DB >> 26512716

From Genes to Mechanisms: The Expanding Spectrum of Monogenic Disorders Associated with Inflammatory Bowel Disease.

Holm H Uhlig1, Tobias Schwerd.   

Abstract

Inborn errors of the intestinal epithelial barrier function as well as the innate and adaptive mucosal immune responses toward the intestinal microbiota are a group of genetic disorders that confer susceptibility to monogenic and syndromal forms of inflammatory bowel disease (IBD). There is a continuous spectrum of genetic susceptibility from monogenic causative variants with complete Mendelian inheritance, over NOD2 variants with moderate penetrance to minute penetrance in most common susceptibility variants predisposing to conventional polygenic IBD. We discuss advances to understand monogenic IBD and review recently identified genetic defects. We describe an integrative model for genetic susceptibility variants of conventional IBD and monogenic IBD-like intestinal inflammation in the context of microbial commensal colonization and infection susceptibility.

Entities:  

Mesh:

Year:  2016        PMID: 26512716     DOI: 10.1097/MIB.0000000000000614

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  27 in total

Review 1.  The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies.

Authors:  Dror S Shouval; Matthew Kowalik; Scott B Snapper
Journal:  J Clin Immunol       Date:  2018-06-29       Impact factor: 8.317

Review 2.  Inflammatory Bowel Disease in Primary Immunodeficiencies.

Authors:  Judith R Kelsen; Kathleen E Sullivan
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

3.  A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant.

Authors:  Alina Kurolap; Orly Eshach Adiv; Liza Konnikova; Lael Werner; Claudia Gonzaga-Jauregui; Maya Steinberg; Vanessa Mitsialis; Adi Mory; Moran Y Nunberg; Sarah Wall; Ron Shaoul; John D Overton; Alan R Shuldiner; Yaniv Zohar; Tamar Paperna; Scott B Snapper; Dror S Shouval; Hagit Baris Feldman
Journal:  J Clin Immunol       Date:  2019-05-11       Impact factor: 8.317

4.  Novel ZBTB24 Mutation Associated with Immunodeficiency, Centromere Instability, and Facial Anomalies Type-2 Syndrome Identified in a Patient with Very Early Onset Inflammatory Bowel Disease.

Authors:  Máire A Conrad; Noor Dawany; Kathleen E Sullivan; Marcella Devoto; Judith R Kelsen
Journal:  Inflamm Bowel Dis       Date:  2017-12       Impact factor: 5.325

Review 5.  How genetic testing can lead to targeted management of XIAP deficiency-related inflammatory bowel disease.

Authors:  Ole Haagen Nielsen; Eric Charles LaCasse
Journal:  Genet Med       Date:  2016-07-14       Impact factor: 8.822

6.  Phenotypic and Genotypic Characterisation of Inflammatory Bowel Disease Presenting Before the Age of 2 years.

Authors:  Jochen Kammermeier; Robert Dziubak; Matilde Pescarin; Suzanne Drury; Heather Godwin; Kate Reeve; Sibongile Chadokufa; Bonita Huggett; Sara Sider; Chela James; Nikki Acton; Elena Cernat; Marco Gasparetto; Gabi Noble-Jamieson; Fevronia Kiparissi; Mamoun Elawad; Phil L Beales; Neil J Sebire; Kimberly Gilmour; Holm H Uhlig; Chiara Bacchelli; Neil Shah
Journal:  J Crohns Colitis       Date:  2016-06-14       Impact factor: 9.071

Review 7.  Very early-onset inflammatory bowel disease: an integrated approach.

Authors:  Kathleen E Sullivan; Maire Conrad; Judith R Kelsen
Journal:  Curr Opin Allergy Clin Immunol       Date:  2018-12

8.  Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease.

Authors:  Mara Cananzi; Aleixo M Muise; Luca Bosa; Vritika Batura; Davide Colavito; Karoline Fiedler; Paola Gaio; Conghui Guo; Qi Li; Antonio Marzollo; Claudia Mescoli; Ryusuke Nambu; Jie Pan; Giorgio Perilongo; Neil Warner; Shiqi Zhang; Daniel Kotlarz; Christoph Klein; Scott B Snapper; Thomas D Walters; Alberta Leon; Anne M Griffiths
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379

9.  Mucosal Invariant T cells are Diminished in Very Early-Onset Inflammatory Bowel Disease.

Authors:  Ying Dou; Kelly Maurer; Maire Conrad; Trusha Patel; Rawan Shraim; Kathleen E Sullivan; Judith Kelsen
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-10-01       Impact factor: 3.288

10.  IFIH1 loss-of-function variants contribute to very early-onset inflammatory bowel disease.

Authors:  Mara Cananzi; Elizabeth Wohler; Antonio Marzollo; Nara Lygia de Macena Sobreira; Helen C Su; Anthony L Guerrerio; Davide Colavito; Jing You; Huie Jing; Silvia Bresolin; Paola Gaio; Renan Martin; Claudia Mescoli; Sangeeta Bade; Jennifer E Posey; Maurizio Dalle Carbonare; Wesley Tung; Shalini N Jhangiani; Luca Bosa; Yu Zhang; Joselito Sobreira Filho; Maria Gabelli; Richard Kellermayer; Howard A Kader; Maria Oliva-Hemker; Giorgio Perilongo; James R Lupski; Alessandra Biffi; David Valle; Alberta Leon
Journal:  Hum Genet       Date:  2021-06-29       Impact factor: 5.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.